Table 2.
The prevalence of MTHFR mutation in ALL cases and its association with control group.
| MTHFR mutation | Responses | Case (50) | Control (50) | p value | ||
|---|---|---|---|---|---|---|
| Count | % | Count | % | |||
| Detection | Yes | 12 | 24.0 | 0 | 0 | 0.001* |
| No | 38 | 76.0 | 50 | 100 | ||
The prevalence of MTHFR mutation among cancer patents is 24.0%.
p value ≤ 0.05.